论文部分内容阅读
药物警戒旨在通过评价、认识和预防不良反应及所有药物相关问题改善患者的安全性,作为一门学科,药物警戒在过去十年取得巨大发展,但全球的需求及优先工作不同,一些国家以高负担疾病为工作重点,而另一些国家则由透明及信息的获取驱动。本着患者安全的最终目标,近年来,发达国家的药物警戒在药品安全性信息收集、管理、分析使用等方面正朝着“药物警戒质量管理规范”发展。发展中国
Pharmacovigilance aims to improve patient safety by assessing, recognizing and preventing adverse drug reactions and all drug-related issues. As a discipline, pharmacovigilance has seen tremendous growth over the past decade, but global needs and priorities are different, with some countries High burden of disease is a priority, while others are driven by transparency and access to information. In line with the ultimate goal of patient safety, in recent years, drug warnings in developed countries are moving toward the “Code of Pharmacy Warning Quality Management” in terms of information collection, management, analysis and use of drug safety information. Developing China